The COVID-19 pandemic has led to multiple changes in maternity services worldwide. Systems rapidly adapted to meet public health requirements aimed at preventing transmission of SARS-CoV-2, including quarantine procedures, travel restrictions, border closures, physical distancing and "stay-at-home" orders. Although these changes have impacted all stakeholders in maternity services, arguably the women at the center of this care have been most affected. This study aimed to explore women's experiences of receiving maternity care during the COVID-19 pandemic in Australia.
 
  A national cross-sectional online survey, including fixed choice and open-ended questions, was conducted during the first wave of the COVID-19 pandemic in Australia; pregnant and postnatal women were recruited through social media networks.
 
  The survey was completed by 3364 women. Women felt distressed and alone due to rapid changes to their maternity care. Limited face-to-face contact with health practitioners and altered models of care ofth crises.Development of visible-light-responsive oxynitride photocatalysts has been highly inspired for promising solar-to-chemical conversion, but the number of Ti-based oxynitrides is scarce because of the relatively low thermal stability of Ti4+ ions under ammonia flow. Here, the feasible synthesis of a novel perovskite SmTiO2 N from the layered NaSmTiO4 precursor is demonstrated to exhibit wide visible-light response with a bandgap of ≈2.1 eV and to show effective water reduction and oxidation functionalities under visible-light irradiation. The successful preparation mainly results from the synergistic effect of the layered structure of NaSmTiO4 and the evaporation spillover of Na+ ions, both of which are favorable for ammonia diffusion to accelerate the substitution of nitrogen to oxygen atoms and to shorten the nitridation time. The thermodynamic and kinetic feasibility of SmTiO2 N for water splitting are investigated in detail, and its optimal apparent quantum efficiency (AQE) of water oxidation reaches 16.7% at 420 ± 10 nm, higher by far than that of most previous visible-light-responsive photocatalysts. Interestingly, a series of oxynitrides RTiO2 N (R = La, Pr, Nd) are similarly synthesized by the alkali-metal evaporation-assisted layered-precursor strategy, demonstrating its generality to prepare visible-light-responsive (oxy)nitride photocatalysts containing reducible metals for solar energy conversion.Double chambered left ventricle is an exceedingly rare congenital anomaly. We report a case diagnosed prenatally at 24 weeks of gestation and its postnatal evolution to left ventricular dysfunction.
  Interleukin (IL)-31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases.
 
  To demonstrate the efficacy and safety of lokivetmab (canine anti-IL-31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
 
  Dogs that were at least moderately pruritic with a presumptive diagnosis of allergic dermatitis were enrolled in Portugal, Hungary, France and Germany by 12 primary care practitioners and two veterinary dermatology referral specialists.
 
  Dogs were randomised to receive either placebo (saline) or lokivetmab (1.0-3.3mg/kg) by subcutaneous injection on Day (D)0. Owners evaluated pruritus using a validated Visual Analog Scale (pVAS) daily until D7 and then weekly until D28.  https://www.selleckchem.com/products/alkbh5-inhibitor-2.html  The severity of dermatitis was assessed by the investigators using a modified VAS on D0, D7, D14 and D28.
 
  Beginning at D1, owner-assessed pVAS least square means were significantly reduced in the treatment group versus the placebo group (57.7% versus 21.8% reduction on D28). For all time points, investigator-assessed VAS means were significantly reduced in the lokivetmab group versus the placebo group (57.1% versus 20.5% reduction on D28). Overall, the occurrence of adverse health events during the evaluation period was comparable between the two groups.
 
  Lokivetmab is a safe and efficacious treatment for dogs with allergic dermatitis.
 Lokivetmab is a safe and efficacious treatment for dogs with allergic dermatitis.
  Caparinia tripilis is a common ectoparasitic mite affecting African pygmy hedgehogs, and is associated with pruritus and self-trauma. There have been no published surveys on the prevalence of such mites in pet African pygmy hedgehogs in Italy.
 
  To evaluate the prevalence and clinical signs of C.tripilis infestation in African pygmy hedgehogs.
 
  Clinical records of hedgehogs examined between December 2017 and December 2020 were searched retrospectively.
 
  The prevalence of C.tripilis infestation was evaluated and exposure variables were assessed using stepwise conditional logistic regression and odds ratios (OR) were calculated.
 
  The overall prevalence of C.tripilis was 39.5% (81 of 205) in client-owned and 81.5% (66 of 81) in pet shop-housed affected hedgehogs. Fifty-two hedgehogs (64.2%) showed clinical signs of pruritus, scales, erythema, spine loss, crusting, alopecia and lichenification, while 29 infested hedgehogs (35.8%) were asymptomatic. The head was the most frequently affected area in 30 of 81 (37%) animals. In a multivariable analysis, affected hedgehogs were significantly younger [OR 0.27, 95% confidence interval (CI) 0.1-0.73; P=0.0097] and more likely to be from a pet shop (OR 2.1, 95%CI 1-4.4; P=0.04) than unaffected hedgehogs.
 
  The results of this study indicate a prevalence rate of C.tripilis infestation that is consistent with trends observed in other studies. African pygmy hedgehogs, especially younger animals and those originating from a pet shop, should always be evaluated for C.tripilis.
 The results of this study indicate a prevalence rate of C. tripilis infestation that is consistent with trends observed in other studies. African pygmy hedgehogs, especially younger animals and those originating from a pet shop, should always be evaluated for C. tripilis.Human uterus transplantation (UTx)-the most radical and experimental of all current forms of assisted reproduction-gives rise to a range of complex ethical questions, including those related to individual safety, risk, and informed consent. I have argued elsewhere that the wider social impacts and implications of UTx provision must form part of a comprehensive ethical analysis. My socio-moral critique of UTx provision has been responded to with a number of defences of possible public funding of UTx. In this paper I examine a select number of those defences. These include that UTx provision would address harms and needs that already exist and as such have priority; that UTx provision is fully compatible with the needed reform of the procreative context in which it would be offered; that UTx provision would not necessarily involve legitimation or endorsement of what are widely agreed to be problematic pronatalist or geneticist norms; and that UTx provision is required as a matter of justice and consistency with other practices.